In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.
Bordetella bronchiseptica chronically infects a wide range of mammals, and resides primarily in the nasal cavity of the infected host. Multiple virulence factors of Bordetella species have been studied in the context of lower respiratory tract infections, but relatively less is known about the bacterial life cycle in the nasal cavity. Evidences were discovered for Bvg intermediate (Bvg(i)) phase expression in vivo and that the major adhesin filamentous hemagglutinin plays a major role in the colonization of B. bronchiseptica in the unciliated olfactory epithelia of the nasal cavity.
Irie
Yasuhiko
Y
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Yuk
Ming H
MH
D018829:Adhesins, Bacterial / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D001885:Bordetella Infections / Q000382:microbiology; D016950:Bordetella bronchiseptica / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism / Q000472:pathogenicity*; D004848:Epithelium / Q000382:microbiology; D015964:Gene Expression Regulation, Bacterial; D051379:Mice; D008810:Mice, Inbred C57BL; D009296:Nasal Cavity / Q000166:cytology / Q000382:microbiology*; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D010566:Virulence Factors, Bordetella / Q000235:genetics / Q000378:metabolism*
D018829:Adhesins, Bacterial; D001426:Bacterial Proteins; D015534:Trans-Activators; D010566:Virulence Factors, Bordetella
J Exp Med. 1991 May 1;173(5):1143-9
2022924
Pharm Res. 1990 Aug;7(8):863-8
2235883
Infect Immun. 1993 Jul;61(7):2780-5
8514379
Infect Immun. 1994 Aug;62(8):3381-90
8039908
J Exp Med. 1994 Oct 1;180(4):1225-33
7931059
Cell. 1995 Feb 24;80(4):611-20
7867068
Mol Microbiol. 1997 May;24(4):671-85
9194696
Infect Immun. 1997 Dec;65(12):5295-300
9393829
Infect Immun. 1998 Dec;66(12):5921-9
9826374
Infect Immun. 1999 Mar;67(3):1493-500
10024599
Infect Immun. 2005 Jan;73(1):308-16
15618167
Trends Microbiol. 2005 Jan;13(1):7-10
15639625
Infect Immun. 2005 Feb;73(2):748-60
15664913
Mol Microbiol. 2005 Apr;56(1):175-88
15773988
Clin Microbiol Rev. 2005 Apr;18(2):326-82
15831828
Infect Immun. 2005 Jun;73(6):3618-26
15908391
Mol Microbiol. 2005 Oct;58(1):267-79
16164564
Curr Opin Microbiol. 2006 Feb;9(1):69-75
16406775
J Bacteriol. 2006 Mar;188(5):1775-85
16484188
J Biol Chem. 2006 Mar 10;281(10):6589-600
16407269
Trends Microbiol. 2005 Aug;13(8):355-9
15990312
Mol Microbiol. 2000 Mar;35(5):991-1004
10712682
Mol Microbiol. 2001 Jan;39(1):65-78
11123689
FEMS Microbiol Rev. 2001 May;25(3):309-33
11348687
Trends Microbiol. 2003 Aug;11(8):367-73
12915094
J Immunol. 2004 Aug 1;173(3):1934-40
15265927
J Bacteriol. 2004 Sep;186(17):5692-8
15317773
J Gen Microbiol. 1970 Oct;63(2):211-20
4324651
J Appl Physiol Respir Environ Exerc Physiol. 1980 Aug;49(2):319-25
6772618
Cell. 1990 Jun 29;61(7):1375-82
2364431
Environ Health Perspect. 1990 Apr;85:187-208
2200662
Pharm Res. 1991 Jul;8(7):807-14
1924131